By bertrand
20 patients treated in our on-going European Valvosoft® Pivotal Study ! February 27th 2023 As of end of January 2023, a total of 20 patients affected with Aortic Stenosis have been treated with Cardiawave ’s non-invasive ultrasound therapy medical device combining ultrasound therapy, robotics and ultrasound imaging, in our on-going European Valvosoft® Pivotal Study ! Congratulations to:Amphia … Continued
By bertrand
13/02/2023 Cardiawave granted 3 new patents extending its intellectual property protection for its technology in the United States. DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
Article Cordiam February 2nd 2023 Un grand merci au Prof. Emmanuel Messas #HEGP Hôpital Européen Georges-Pompidou , AP-HP, Assistance Publique – Hôpitaux de Paris, qui retrace dans #Cordiam l’aventure Cardiawave. Il décrit comment son « rêve de cardiologue est devenu réalité » : de bientôt mettre à disposition des patients atteints de sténose aortique, maladie dégénérative très fréquente chez les + de 70 ans, un dispositif médical unique … Continued
By bertrand
Nous sommes fiers d’annoncer que Cardiawave vient de devenir membre de la French Care ! January 23th 2023 Nous sommes fiers d’annoncer que Cardiawave vient de devenir membre de la French Care ! En rejoignant cette communauté de leaders de l’industrie de la santé et des soins en France, nous avons l’opportunité de développer nos collaborations avec … Continued
By bertrand
Journées Européennes de la SFC 2023 (cardio-online) Jan. 11-13 – Paris January 11th 2023 Cardiawave is attending one of the major European scientific and medical annual symposium JESFC 2023 featuring major medical research breakthroughs. Leading researchers and clinicians will be discussing the latest evidence-based research. JESFC provides cardiologists and other cardiovascular healthcare professionals with everything they need to improve patient … Continued
By bertrand
2023 is shaping up to be an exceptional year for Cardiawave ! January 9th 2023 Our European “Valvosoft® Pivotal Study” is proceeding as planned, and we are extremely pleased to announce that 3 patients with aortic stenosis, the most common heart valve disease in adults, have been treated with our non-invasive ultrasound therapy (NIUT) device at the Amphia Hospital in Breda, the Netherlands. … Continued
By bertrand
SNITEM : 10èmes rencontres du progrès médical le 13 décembre 2022 à l’Institut Pasteur December 7th 2022 Que fait-on des innovations technologiques en santé ?Arrivent-elles toujours au patient ? Dans quel délai ? Partout en France ? Benjamin BERTRAND – CEO Cardiawave – co-intervenant de la table ronde à 11h30 sur ” l’echo thérapie, des technologies de moins en moins invasives” à … Continued
By bertrand
The entire team is pleased and proud to have obtained the renewal of the EN ISO 13485: 2016 certification ! November, 4th 2022 The entire Cardiawave team is pleased and proud to have obtained the renewal of the EN ISO 13485: 2016 certification ! Issued after an audit by Dekra Certification BV, an independent certification body of international … Continued
By bertrand
Medical device on its way to Breda! November 21th 2022 Enjoy! 🙌 💪 And here is one of our investigational medical devices ready and on its way to Amphia Ziekenhuis Hospital in Breda, The Netherlands to allow patients suffering from aortic stenosis, the most common heart valve disease in adults, to benefit from a unique non-invasive ultrasound therapy (NIUT). #echotherapy #heartvalvedisease #aorticstenosis #heartfailure #cardiology #focusedultrasounds #SMEInstrument #RHUStopAS #Medtech #Deeptech #healthtech #health
By bertrand
Healthtech in Progress November 8th 2022 Nous avons le plaisir de partager le podcast Healthtech in Progress où notre CEO Benjamin BERTRAND, se prête au jeu de l’interview par Mériadec Gaignard. Découvrez la vision de l’entrepreneuriat par Benjamin, sa volonté chevillée au corps de mettre la science et l’innovation technologique au cœur des avancées sociétales; comment il s’est … Continued
